Credit Suisse Group initiated coverage on shares of UnitedHealth Group Incorporated (NYSE:UNH) in a research note issued to investors on Thursday. The brokerage issued an outperform rating and a $233.00 price objective on the healthcare conglomerate’s stock.
UNH has been the topic of several other research reports. Barclays PLC boosted their price target on shares of UnitedHealth Group from $200.00 to $217.00 and gave the company an overweight rating in a report on Wednesday, July 19th. Leerink Swann reissued a buy rating and issued a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Zacks Investment Research raised shares of UnitedHealth Group from a hold rating to a buy rating and set a $219.00 price target on the stock in a report on Thursday, September 21st. Cowen and Company reissued a buy rating on shares of UnitedHealth Group in a report on Friday, July 14th. Finally, Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group to $225.00 and gave the company an overweight rating in a report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $216.65.
Shares of UnitedHealth Group (UNH) traded up $1.77 during mid-day trading on Thursday, reaching $212.87. 2,196,909 shares of the company were exchanged, compared to its average volume of 3,707,661. UnitedHealth Group has a fifty-two week low of $136.22 and a fifty-two week high of $213.83. The company has a market capitalization of $205,815.48, a price-to-earnings ratio of 22.17, a P/E/G ratio of 1.58 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.72.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.17 earnings per share. equities analysts anticipate that UnitedHealth Group will post 9.99 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2017/11/05/unitedhealth-group-incorporated-unh-earns-outperform-rating-from-analysts-at-credit-suisse-group.html.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares in the company, valued at approximately $38,755,268.75. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 72,149 shares of company stock worth $14,212,342. Corporate insiders own 0.89% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in the business. HL Financial Services LLC lifted its position in UnitedHealth Group by 18.1% during the 3rd quarter. HL Financial Services LLC now owns 16,201 shares of the healthcare conglomerate’s stock valued at $3,173,000 after purchasing an additional 2,482 shares during the period. Suffolk Capital Management LLC increased its stake in shares of UnitedHealth Group by 14.5% in the 3rd quarter. Suffolk Capital Management LLC now owns 59,187 shares of the healthcare conglomerate’s stock valued at $11,592,000 after acquiring an additional 7,491 shares during the last quarter. FDx Advisors Inc. increased its stake in shares of UnitedHealth Group by 11.5% in the 3rd quarter. FDx Advisors Inc. now owns 52,491 shares of the healthcare conglomerate’s stock valued at $10,280,000 after acquiring an additional 5,431 shares during the last quarter. Jennison Associates LLC increased its stake in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after acquiring an additional 3,289,470 shares during the last quarter. Finally, Corundum Group Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $234,000. Institutional investors own 86.14% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.